Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial

Gastroenterology

Volumn 111, Issue 3, 1996, Pages 710-715

  Klein, A S ^a   Cofer, J B ^a   Pruett, T L ^a   Thuluvath, P J ^a   McGory, R ^a   Uber, L ^a   Stevenson, W C ^a   Baliga, P ^a   Burdick, J F ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROSTAGLANDIN E1; CREATININE; CRYSTALLOID SOLUTIONS; ISOTONIC SOLUTION; ORAL REHYDRATION SOLUTION; PLASMA SUBSTITUTE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GRAFT FAILURE; HUMAN; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; ADULT; BLOOD; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; FEMALE; INFUSION; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROSPECTIVE STUDY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADULT; ALPROSTADIL; BLOOD UREA NITROGEN; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, PARENTERAL; INTENSIVE CARE UNITS; ISOTONIC SOLUTIONS; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; REHYDRATION SOLUTIONS; TREATMENT OUTCOME;

EID: 0029665262     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1996.v111.pm8780576     Document Type: Article

References (0)